共 119 条
[1]
Roger VL(2011)Heart disease and stroke statistics--2011 update: a report from the American Heart Association Circulation 123 e18-e209
[2]
Go AS(2014)The burden of acute heart failure on U.S. emergency departments JACC Heart failure 2 269-77
[3]
Lloyd-Jones DM(2010)Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine Eur J Heart Fail 12 423-33
[4]
Adams RJ(2016)Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure ESC heart failure 3 177-88
[5]
Berry JD(2007)Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 1319-31
[6]
Brown TM(2008)Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial J Am Coll Cardiol. 52 1540-5
[7]
Storrow AB(2015)The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials Heart Fail Rev 20 633-42
[8]
Jenkins CA(2015)Arginine vasopressin antagonist tolvaptan in the treatment of heart failure: a meta-analysis of randomized controlled trials Int J Clin Exp Med 8 22117-22128
[9]
Self WH(2016)Tolvaptan for heart failure, systematic review and meta-analysis of trials J Cardiovasc Pharmacol 68 196-203
[10]
Alexander PT(2016)Clinical effectiveness of Tolvaptan in patients with acute heart failure and renal dysfunction J Card Fail 22 423-32